One hundred twenty barrows (initially 59 kg) were used to determine the effects of dietary lysine and porcine somatotropin (pST) on growth performance and carcass characteristics of finishing pigs fed to heavy market weights (127 kg). Pigs were injected daily with either 4 mg of pST or a placebo and fed diets containing either .8, 1.0, 1.2, or 1.4% lysine in a 2 x 4 factorial arrangement. Performance data were collected and evaluated for the weight ranges: 59 to 105, 105 to 127, and 59 to 127 kg. In addition, daily accretion rates of protein (DPA), lipid (DLA), moisture, and ash were determined by slaughtering six randomly selected pigs at the start of the experiment, then one pig per pen when pigs reached mean weights of 105 and 127 kg. Pigs injected with pST had greater (P < .05) ADG than control pigs at all weight ranges. Increased dietary lysine had no effect (P > .20) on ADG during the entire trial (59 to 127 kg). Although control pigs showed no increase in ADG with increasing lysine, ADG of pST-treated pigs tended to increase. This resulted in a pST x lysine interaction (P < .07) for ADG from 59 to 127 kg. Feed consumption decreased (P < .05) in pigs from 59 to 105 kg and 59 to 127 kg with pST treatment and with increasing dietary lysine. Feed conversion (G/F) was improved (P < .01) by pST administration and a tendency for a pST x lysine interaction (P < .12) was observed. At 105 kg, average backfat thickness, kidney fat, longissimus muscle area, and DPA were unaffected by dietary lysine but were improved by pST treatment (P < .01). At a slaughter weight of 127 kg, average backfat thickness decreased and DPA increased (linear, P < .05) with increasing dietary lysine and pST treatment (P < .01). Longissimus muscle area was increased and DLA was decreased (P < .01) by injections of pST but both were unchanged by dietary lysine. These data indicate that growth performance and carcass characteristics at 105 and 127 kg were improved by daily administration of 4 mg of pST. At both slaughter weights, increasing dietary lysine resulted in increased carcass leanness (increased carcass protein and decreased carcass lipid). Although increasing lysine did not improve overall (59 to 127 kg) ADG and feed efficiency, pST-treated pigs showed a greater response to increasing dietary lysine. The data indicate that pST-treated pigs (4 mg/d) require approximately 28 g/d of lysine.
Seventy-two barrows (initial weight = 57.1 kg) were used to determine the interrelationship between porcine somatotropin (pST) and dietary lysine and their effects on growth performance and carcass characteristics. Pigs were injected daily in the extensor muscle of the neck with either 4 or 8 mg of pST and fed a pelleted corn-soybean meal-sesame meal diet (.8% lysine; 17.8% CP) or diets containing 1.0, 1.2, or 1.4% lysine provided by additions of L-lysine.HCl (2 x 4 factorial arrangement). Control pigs (placebo injection) received the .8% lysine diet. All diets were formulated to contain > or = 200% of current recommendations for other amino acids, vitamins, and minerals. A tendency for a pST x lysine interaction was observed for cumulative ADG (P < .15) and feed conversion (G/F; P < .05). Average daily gain and G/F were improved by increasing dietary lysine level in pigs injected with 4 mg/d of pST; however, pigs injected with 8 mg/d of pST had greater improvements in cumulative ADG and G/F with added lysine. Feed intake was reduced (quadratic, P < .10) as dietary lysine level and pST dosage increased. Increasing pST dosage and dietary lysine increased (linear, P < .05) longissimus muscle area and decreased backfat thickness. Trimmed ham and loin weights were increased (linear, P < .10) by pST dosage. Chemical composition of samples taken from the loin, ham, and belly indicated increased moisture and CP and decreased lipid content as pST dosage and dietary lysine level increased (quadratic, P < .05). Shear force values from loin and semimembranosus increased with increasing lysine level (quadratic, P < .01) and pST dosage (linear, P < .05); however, these differences were not detected by sensory analysis (P > .20). Plasma urea concentrations on d 28 decreased with increasing lysine level (quadratic, P < .05), and plasma lysine concentrations increased (linear, P < .01). Based on the pST x lysine interaction for ADG and G/F, these data suggest that the lysine level needed to maximize growth performance and carcass characteristics may be proportional to the pST dosage provided. Growth and carcass characteristics were maximized by dietary lysine intakes of 27 to 32 and > or = 36 g/d for pigs injected with 4 and 8 of mg/d of pST, respectively.
The femur, a rib, and a third metacarpal were collected from 108 barrows (initial weight = 57 kg) and analyzed to determine the effects of porcine somatotropin (pST) and dietary lysine on bone mineralization and mechanical properties. In Exp. 1, pigs were injected daily with 4 mg of pST and fed diets containing 1.0% Ca and .9% P and either .6, .8, 1.0, 1.2, or 1.4% lysine. Control pigs (placebo injection) received the .6% lysine diet. Bone wall thickness (BWT) of the femur increased (linear, P < .05) but ash content decreased (linear, P < .10) as dietary lysine level increased. Stress and ash content of the rib also decreased (linear, P < .05) with increasing dietary lysine level. In Exp. 2, pigs were injected with either 4 or 8 mg/d of pST and fed diets containing 1.1% Ca and 1.0% P and either .8, 1.0, 1.2, or 1.4% lysine. Control pigs received the .8% lysine diet. Increasing pST dosage increased BWT of the femur (linear, P < .10) but decreased ash content (linear, P < .10). In the rib, increasing pST dosage reduced stress, modulus of elasticity (linear, P < .10), and ash content (linear, P < .01). Increasing lysine level resulted in increased BWT of the femur and decreased ash content of rib, femur, and metacarpal (linear, P < .10). These data indicate that pST administration in conjunction with increasing lysine levels decreases bone ash content but increases BWT of finishing pigs.
An experiment was conducted to evaluate the interactive effects among porcine somatotropin (pST), salbutamol, and dietary lysine on growth performance, nitrogen balance, and carcass characteristics of finishing barrows (n = 32; 62.8 kg initially). Two replicate 32-d studies were set up in a split-plot design to evaluate singular and combined use of pST (0 or 4 mg/d) and salbutamol (0 or 2.75 ppm of the diet) as whole-plot treatments and diets containing .8, 1.2, 1.6, or 2.0% lysine as subplot treatments. Dietary lysine levels were administered within subplots in a 4 x 4 Latin square with pigs allowed 4 d of adjustment to diets followed by 4 d of urine and feces collection for determination of N retention and apparent digestibility of DM and N. Interactions between lysine and salbutamol were not found (P > .16). A pST x lysine interaction (P < .05) resulted in ADG being maximized at 1.2% lysine for pST-treated pigs (lysine quadratic, P < .02) but decreased linearly (P < .02) with increasing lysine for pigs receiving buffer. Pigs injected with 4 mg/d of pST had improved gain:feed (G:F) up to 1.2% lysine (lysine quadratic, P < .05), but no further increase to 2% lysine, whereas pigs injected with buffer showed no benefit from increased lysine (pST x lysine, P < .06). Pigs receiving buffer had greater increases in plasma urea N (PUN) as lysine increased than those receiving pST (pST x lysine, P < .002), but PUN was reduced by pST (P < .001) regardless of lysine level.(ABSTRACT TRUNCATED AT 250 WORDS)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.